{"doi":"10.1056/nejme2033311","title":"Stimulation of Contractility in Systolic Heart Failure","abstract":null,"journal":"New England Journal of Medicine","year":2021,"id":619444,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":92423,"name":"Karl Swedberg","orcid":"0000-0002-6358-2154","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Stimulation of Contractility in Systolic Heart Failure","abstract":"The treatment of patients with heart failure and reduced myocardial contractility (i.e., systolic failure) has been and remains a challenge. Increasing contractility by stimulation with pharmaceutical agents has consistently failed to improve outcomes and has often resulted in increased mortality.1 In contrast, treatments with no effect or even a negative effect on contractility — such as angiotensin-converting–enzyme inhibitors and beta-adrenergic receptor blockers — have been shown to improve outcomes. The harmful effect of previously studied inotropic agents has been shown to be related to the mechanism of action of these drugs; stimulation of contractility through modulation of myocardial cyclic AMP . . .","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33497552","pmcid":null,"openalex_id":"https://openalex.org/W3120877812","authors":[],"funders":[],"total_grants":0,"fwci":0.2923,"citation_percentile":0.55001565,"influential_citations":0,"citation_trend":[{"year":2021,"count":1},{"year":2023,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"http://www.nejm.org/doi/pdf/10.1056/NEJMe2033311","host_type":"publisher"},{"url":"https://doi.org/10.1056/nejme2033311","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33497552","host_type":"repository"}],"fields_of_study":["Heart Failure Treatment and Management","Cardiac pacing and defibrillation studies","Cardiovascular Function and Risk Factors","Heart Failure","Heart Failure, Systolic","Humans","Urea"],"mesh_terms":["Heart Failure","Humans","Urea","Heart Failure, Systolic"],"keywords":["Contractility","Inotrope","Heart failure","Internal medicine","Stimulation","Medicine","Cardiology","Endocrinology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-03T07:12:20.939349Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}